Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,045-1,056 of 4,306
Behavioral study icon
CompletedNCT05345977

eMotiph: E-mental Health Solution for people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Barcelona
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
Spain
Sponsor
Grupo Pulso
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT02926859

Enhancing Recovery in Early Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Mannheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
Other study type icon
CompletedNCT05257720

Evaluation of the Role of Neurodegeneration in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Istanbul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 65 Years
Countries
Türkiye
Sponsor
Istanbul Saglik Bilimleri University
Condition
Schizophrenia
Drug study icon
CompletedNCT00236548

Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which adults with Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection

This study is completed. It focuses on schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00916201

Evaluation Study of New Compounds With Potential Use in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Mannheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05438160

Exploratory Study of a Digital Therapeutics in People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT04941677

Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control

This summary needs review. Please check the official study record and contact the research team for details.

In Tainan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 20 Years to 65 Years
Countries
Taiwan
Sponsor
National Cheng-Kung University Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.